Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving chemotherapy and total-body irradiation before a donor umbilical cord blood
transplant helps stop the growth of cancer and abnormal cells and helps stop the patient's
immune system from rejecting the donor's stem cells. When the stem cells from a related or
unrelated donor, that do not exactly match the patient's blood, are infused into the patient
they may help the patient's bone marrow to make stem cells, red blood cells, white blood
cells, and platelets.
PURPOSE: This clinical trial is studying how well donor umbilical cord blood transplant works
in treating patients with hematologic cancer.